Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

December 31, 2016

Conditions

Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1a

Interventions

DRUG

Ombitasvir/ABT-450/Ritonavir

Ombitasvir/ABT-450/ritonavir combination tablets

DRUG

Dasabuvir

Dasabuvir tablets

DRUG

Ribavirin (RBV)

Ribavirin tablets